PI4KIIIbeta-IN-10是一种高效的PI4KIIIβ抑制剂，IC50为3.6 nM。

UNC3230 is a PIP5K1C inhibitor. It lowered PIP2 levels in DRG neurons and attenuated hypersensitivity when administered intrathecally or into the hindpaw.

BQR695 is a PI4K specific inhibitor with IC50 value of 80nM.

KDU691 is a plasmodium PI(4)K inhibitor which selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites.

PI-273 is a substrate-competitive, specific small molecule inhibitor of PI4KIIα which inhibits the growth of breast cancer cells.

MMV390048 is an antimalarial compound belonging to the aminopyridine class for treating malaria. It is efficacious against all Plasmodium life cycle stages, apart from late hypnozoites in the liver.

PIK-93 is the potent, synthetic PI4K (PI4KIIIβ) inhibitor with IC50 of 19 nM, and shown to inhibit PI3Kα with IC50 of 39 nM.

KDU731, a cryptosporidium PI(4)K inhibitor, is a drug candidate for cryptosporidiosis.

ISA-2011B is a PIP5Kα (Phosphatidylinositol-4-phosphate 5-kinase-α) inhibitor.

PI4KIII beta inhibitor 3 is a high effective PI4KIII beta inhibitor with IC50 of 5.7 nM.

UCB9608 is inhibitor of PI4KIIIβ with IC50 of 11 nM and can improve metabolic stability. It is used as an immunosuppressive agent.